Frontiers | Immunotherapy for Hepatocellular Carcinoma: Current Limits and Prospects
Clinical challenges in cancer patients with COVID-19: Aging, immunosuppression, and comorbidities | Aging
Frontiers | Dissecting the Multiplicity of Immune Effects of Immunosuppressive Drugs to Better Predict the Risk of de novo Malignancies in Solid Organ Transplant Patients
Cancer Risk Among Immunosuppressed Populations - NCI
Perspectives of solid organ transplant recipients on medicine‐taking: Systematic review of qualitative studies - Tang - 2021 - American Journal of Transplantation - Wiley Online Library
Evaluation of Changes Over Time in the Drug Burden and Medication Regimen Complexity in ESRD Patients Before and After Renal Transplantation - ScienceDirect
![PDF] Radiotherapy and Immunotherapy for Cancer: From “Systemic” to “Multisite” | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9ac5e5e50d735ecf3baed58f3854dd1fa050a509/4-Figure1-1.png "PDF] Radiotherapy and Immunotherapy for Cancer: From “Systemic” to “Multisite” | Semantic Scholar")
PDF] Radiotherapy and Immunotherapy for Cancer: From “Systemic” to “Multisite” | Semantic Scholar
Transplantology | Free Full-Text | Strategies to Improve Immune Suppression Post-Liver Transplantation: A Review
Managing immunosuppressive therapy in potentially cured post‐kidney transplant cancer (excluding non‐melanoma skin cancer): an overview of the available evidence and guidance for shared decision‐making - Hellemans - 2021 - Transplant International -
Burden of illness among patients with severe aplastic anemia who have had insufficient response to immunosuppressive therapy: a multicenter retrospective chart review study | Request PDF
Role of tumor microenvironment in EGFR-mutated NSCLC in influencing... | Download Scientific Diagram
Myeloid immunosuppression and immune checkpoints in the tumor microenvironment | Cellular & Molecular Immunology
Tumor mutational burden and immunotherapy in gliomas: Trends in Cancer
Systemic immunity in cancer | Nature Reviews Cancer
Corticosteroid and Immunosuppressant Therapy for Cardiac Sarcoidosis: A Systematic Review | Journal of the American Heart Association
Frontiers | The immunosuppressive microenvironment and immunotherapy in human glioblastoma
Immunosuppression for immune-related adverse events during checkpoint inhibition: an intricate balance | npj Precision Oncology
Immunotherapy combined with radiotherapy to reverse immunosuppression in microsatellite stable colorectal cancer | SpringerLink
Matter of TIME: the tumor-immune microenvironment of mesothelioma and implications for checkpoint blockade efficacy | Journal for ImmunoTherapy of Cancer
Using radiation to modulate CAR T cell function | Carl DeSelm Lab | Washington University in St. Louis
Frontiers | Immunotherapy for Glioblastoma: Current Progress and Challenges
Cells | Free Full-Text | Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Cancer and Immunotherapy
Mutational burden, MHC-I expression and immune infiltration as limiting factors for in situ vaccination by TNFα and IL-12 gene electrotransfer - ScienceDirect
Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success? - ScienceDirect
Frontiers | Immunosuppression in Glioblastoma: Current Understanding and Therapeutic Implications
Zoledronic Acid–Gadolinium Coordination Polymer Nanorods for Improved Tumor Radioimmunotherapy by Synergetically Inducing Immunogenic Cell Death and Reprogramming the Immunosuppressive Microenvironment | ACS Nano
